Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AIG Asset Management is an internal asset management and investment advisory business within the American International Group ecosystem. The entity commonly identified as AIG Asset Management (U.S.), LLC provides discretionary investment advisory and portfolio management services primarily to AIG and its affiliates, with a strong emphasis on fixed income and other institutional asset classes. It is a financial services and insurance-investment organization rather than a biotechnology, pharmaceutical, or healthcare operating company. Historical references to AIG Investments describe a broader global asset management franchise, but that brand is generally treated as a legacy or closed operating identity. For biotech analysts, the key takeaway is that this is an investor/asset manager with possible healthcare investment exposure, not a therapeutic developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AIG Asset Management.